AU1353901A - Method of treating batten disease - Google Patents

Method of treating batten disease

Info

Publication number
AU1353901A
AU1353901A AU13539/01A AU1353901A AU1353901A AU 1353901 A AU1353901 A AU 1353901A AU 13539/01 A AU13539/01 A AU 13539/01A AU 1353901 A AU1353901 A AU 1353901A AU 1353901 A AU1353901 A AU 1353901A
Authority
AU
Australia
Prior art keywords
batten disease
treating batten
treating
disease
batten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13539/01A
Other languages
English (en)
Inventor
Rose-Mary N. Boustany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU1353901A publication Critical patent/AU1353901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13539/01A 1999-12-01 2000-10-30 Method of treating batten disease Abandoned AU1353901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16828799P 1999-12-01 1999-12-01
US60168287 1999-12-01
PCT/US2000/029913 WO2001039760A2 (fr) 1999-12-01 2000-10-30 Methode de traitement de la maladie de batten

Publications (1)

Publication Number Publication Date
AU1353901A true AU1353901A (en) 2001-06-12

Family

ID=22610875

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13539/01A Abandoned AU1353901A (en) 1999-12-01 2000-10-30 Method of treating batten disease

Country Status (2)

Country Link
AU (1) AU1353901A (fr)
WO (1) WO2001039760A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688141A1 (fr) 2005-01-31 2006-08-09 elbion AG Utilisation de flupirtine pour le traitement de la vessie hyperactive et des maladies associées et pour le traitement du syndrome du colon irritable
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen

Also Published As

Publication number Publication date
WO2001039760A3 (fr) 2002-01-17
WO2001039760A2 (fr) 2001-06-07

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
AU2001249881A1 (en) Method of treating the heart
IL145875A0 (en) Novel method of treatment
AU4063600A (en) A method of treating cancer
AU2001240046A1 (en) Method of treating skin conditions
AUPP870999A0 (en) Method of treatment of equine disease
AU3009401A (en) Method of treating fabrics
AU1353901A (en) Method of treating batten disease
GB9930688D0 (en) Novel method of treatment
AU4598400A (en) Method of treatment
AU4985200A (en) Methods of treating hypertension
AU2382601A (en) Novel method of treatment
AU1108101A (en) Method of treating plants
EP1135128A4 (fr) Nouvelle methode therapeutique
AU1784701A (en) Method of treating neuroblastoma
AU8031700A (en) Method of treating fibrosis
GB9930696D0 (en) Novel method of treatment
AU7923600A (en) Method of treating fabric
AUPQ080999A0 (en) Method of treatment
AUPQ320299A0 (en) Method of treatment
AUPQ233299A0 (en) Method of treatment
AUPP986699A0 (en) Method of treating sugar
HUP0003249A3 (en) Method of treating isolated systolic hypertension using eprosartan
AUPP225098A0 (en) Method of treatment
AUPP363398A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase